Artificial Intelligence (AI) In Medical Imaging Market
By Component;
Hardware, Software and ServiceBy Modality;
MRI, CT and X-RayBy Application;
Radiology, Cardio and Cancer - [Lung, Breast and Prostate]By End User;
Hospitals and Imaging CentersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)AI in Medical Imaging Market Overview
AI in Medical Imaging Market (USD Million)
AI in Medical Imaging Market was valued at USD 3,399.12 million in the year 2024. The size of this market is expected to increase to USD 47,835.82 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 45.9%.
Artificial Intelligence (AI) In Medical Imaging Market
*Market size in USD million
CAGR 45.9 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 45.9 % |
Market Size (2024) | USD 3,399.12 Million |
Market Size (2031) | USD 47,835.82 Million |
Market Concentration | Low |
Report Pages | 393 |
Major Players
- Siemens Healthineers
- General Electric
- Koninklijke Philips
- IBM
- Agfa-Gevaert Group/Agfa Health Care
- Arterys
- AZmed
- Caption Health
- Gleamer
- Butterfly Network
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Artificial Intelligence (AI) In Medical Imaging Market
Fragmented - Highly competitive market without dominant players
The AI in Medical Imaging Market is growing steadily as healthcare providers adopt intelligent imaging tools to support clinical decision-making. AI-powered systems enhance image interpretation by detecting patterns and anomalies with high precision. Over 60% of advanced imaging procedures now integrate AI to assist in faster and more accurate diagnostic assessments.
Focus on Improving Accuracy and Diagnostic Efficiency
Medical facilities are using AI to reduce interpretation errors and streamline imaging workflows. More than 55% of implementation efforts are aimed at improving diagnostic reliability, reducing turnaround time, and enhancing detection rates. These systems help radiologists manage large imaging volumes while maintaining high diagnostic confidence.
Support for Early Detection and Clinical Prioritization
AI tools in medical imaging are enabling early identification of abnormalities and assisting with case prioritization. Nearly 45% of AI-based imaging solutions are focused on triaging high-risk cases and highlighting findings that require immediate attention. This contributes to timely interventions and improved patient care coordination.
Innovation in Algorithms and Cloud-Based Imaging Platforms
Vendors are advancing AI through deep learning models and cloud-enabled imaging infrastructure. Approximately 40% of product developments involve enhancing algorithm accuracy, deployment flexibility, and interoperability, allowing seamless integration into clinical settings while supporting scalability and remote accessibility.
Artificial Intelligence (AI) In Medical Imaging Market Key Takeaways
-
Rapid AI adoption is transforming medical imaging, with over 70% of healthcare providers integrating AI tools to enhance diagnostic accuracy and minimize human error.
-
Early disease detection improved through AI-powered imaging solutions, with radiologists reporting up to a 60% increase in identifying abnormalities.
-
Cloud-based AI platforms gain traction, enabling faster image analysis and remote collaboration, boosting efficiency by around 50% across healthcare facilities.
-
Personalized treatment support is driving AI innovations, helping hospitals develop precision medicine initiatives tailored to individual patient needs.
-
Workflow automation enhanced by integrating AI with MRI and CT scans, reducing manual workload by approximately 40% and streamlining imaging operations.
-
Awareness fueling adoption, with more than half of medical institutions planning to expand AI implementation over the next two years due to proven clinical benefits.
-
Predictive analytics strengthened via advanced deep learning algorithms, allowing healthcare providers to anticipate patient risks and optimize treatment strategies.
Artificial Intelligence (AI) in Medical Imaging Market Recent Developments
-
In 2023, Google Health unveiled an AI-powered ultrasound tool that assists clinicians in identifying early-stage cancer. This advancement demonstrates the transformative role of artificial intelligence in medical imaging, improving diagnostic accuracy, enhancing clinical efficiency, and contributing to better patient outcomes.
-
In 2022, Siemens Healthineers launched AI-Rad Companion, an advanced radiology solution leveraging artificial intelligence to deliver automated clinical insights. This innovation enhances diagnostic accuracy by assisting radiologists in interpreting imaging data more efficiently, streamlining workflows, and supporting faster, informed decision-making. It represents a key step in AI-driven medical imaging advancements.
Artificial Intelligence (AI) In Medical Imaging Market Segment Analysis
In this report, the Artificial Intelligence (AI) In Medical Imaging Market has been segmented by Component, Modality, Application, End User and Geography. This structure highlights how drivers such as clinical efficiency, diagnostic accuracy, and workflow automation shape adoption across the ecosystem, while challenges like data quality, integration complexity, and regulatory compliance influence vendor strategies. The following sections examine each axis in order, emphasizing competitive positioning, technology advancements, partnerships, expansion opportunities, and the future outlook for sustainable growth.
Artificial Intelligence (AI) In Medical Imaging Market, Segmentation by Component
The market by Component explores how value accrues across Hardware, Software, and Service layers that together enable AI-driven image acquisition, reconstruction, triage, and reporting. Vendors differentiate through accelerated compute, model libraries, and lifecycle services that reduce total cost of ownership while meeting compliance requirements. Buyers evaluate ROI based on improved throughput, reduced variability, and seamless integration with PACS/RIS, with ecosystem partnerships playing a pivotal role in deployment speed and scale.
Hardware
Hardware underpins performance for training and inference at the edge and in the data center, supporting high-throughput modalities and low-latency workflows. Purpose-built accelerators, GPUs, and embedded AI in scanners enable reconstruction, denoising, and automated quality control with minimal disruption. Procurement decisions emphasize reliability, cybersecurity hardening, and upgrade paths, as providers balance capital budgets with the need for scalable AI capability across networks.
Software
Software delivers clinical algorithms, orchestration, and analytics that translate imaging data into actionable insights. Platforms prioritize interoperability, model monitoring, and explainability to satisfy regulators and clinical governance. Product roadmaps focus on expanding indication coverage, federated learning, and continual updates, while marketplaces and API-first strategies accelerate partnerships with modality OEMs and health IT vendors for broader distribution.
Service
Service offerings—spanning deployment, validation, training, and managed operations—mitigate adoption barriers and ensure sustained performance in live environments. Providers rely on clinical change management, data pipeline setup, and KPI tracking to demonstrate measurable outcomes. Increasingly, outcome-linked contracts and subscription models align incentives, supporting multi-site rollouts and ongoing optimization to keep pace with evolving standards and practice guidelines.
Artificial Intelligence (AI) In Medical Imaging Market, Segmentation by Modality
Segmentation by Modality reflects distinct workflow requirements across MRI, CT, and X-Ray, each offering unique data characteristics and throughput patterns. AI solutions target acceleration, artifact reduction, and lesion detection, while integration with existing image management systems remains a critical challenge. Vendors invest in indication-specific validation and reader studies, and hospitals prioritize solutions that improve radiologist productivity without compromising diagnostic confidence or patient safety.
MRI
MRI benefits from AI-enhanced reconstruction, motion correction, and protocol optimization that reduce scan times and improve image quality. Workflows emphasize standardization across sequences and sites, with AI aiding segmentation and quantification in neuro, musculoskeletal, and body imaging. Partnerships between scanner OEMs and algorithm developers accelerate native feature availability, supporting efficiency gains and patient throughput improvements.
CT
CT leverages AI for noise reduction, low-dose imaging, and rapid triage—particularly in acute settings where time-to-decision is critical. Algorithms target pulmonary, cardiac, and oncologic use cases, streamlining detection and reporting with structured outputs. Health systems weigh scalability across emergency and inpatient pathways, while vendors address regulatory expectations and continuous model performance assurance in heterogeneous fleets.
X-Ray
X-Ray deployments focus on triage, quality checks, and automated detection of common findings across high-volume exams. Cloud connectivity and edge inference enable rapid alerts that reduce reading delays and support workflow orchestration. Buyers emphasize ease of integration, minimal hardware footprint, and support for mobile units, making X-Ray a frequent entry point for AI adoption in resource-constrained environments.
Artificial Intelligence (AI) In Medical Imaging Market, Segmentation by Application
By Application, AI solutions align with specialty-specific clinical pathways in Radiology, Cardio, and Cancer. Each segment requires rigorous evidence, seamless reporting, and fit-for-purpose user experiences to drive adoption. Providers evaluate solutions on accuracy, interoperability, and impact on turnaround times, while vendors expand indications, pursue real-world validation, and cultivate partnerships with academic centers to strengthen credibility and scale.
Radiology
Radiology is the core domain for AI in imaging, covering detection, measurement, triage, and reporting across body systems. Solutions that harmonize with PACS/RIS and support structured reporting unlock measurable productivity gains. As enterprises consolidate tools, platform approaches with centralized governance and usage analytics become preferred, improving quality assurance and budget efficiency.
Cardio
Cardio use cases span coronary calcium scoring, ventricular function, and valvular assessment, emphasizing reproducible quantification and decision support. Interoperability with cardiology information systems and echo/CT/MRI workflows is essential to reduce manual steps. Vendors invest in automation of measurements and longitudinal tracking, helping clinicians manage risk and optimize therapy selection with clearer, evidence-based insights.
Cancer
Cancer applications focus on early detection, treatment planning, and response monitoring across tumor types. Multi-parametric imaging, radiomics, and AI-enabled segmentation support precision oncology by standardizing measurements and facilitating longitudinal comparisons. Collaboration with tumor boards and integration into reporting templates are critical to realize consistent, scalable outcomes across sites.
-
Lung
AI supports nodule detection, malignancy risk scoring, and screening workflows with automated measurements that reduce variability. Seamless integration with CT protocols and quality checks helps manage high volumes and incidental findings. Solutions that provide explainable outputs and structured follow-up recommendations aid communication across multidisciplinary teams and improve pathway adherence.
-
Breast
In breast imaging, AI augments reader performance in mammography and tomosynthesis by improving sensitivity while maintaining specificity. Workflow triage and case prioritization reduce backlogs, and decision support aligns with standardized reporting systems. Emphasis on continuous monitoring, bias mitigation, and regulatory compliance underpins enterprise-wide trust and sustained utilization.
-
Prostate
AI for prostate MRI aids lesion detection, PI-RADS alignment, and volumetric assessment to inform targeted biopsies and treatment planning. Consistent segmentation and report templates support longitudinal comparisons and multidisciplinary care. Vendors focus on reader training tools, calibration across scanners, and interoperability to deliver scalable improvements in diagnostic confidence.
Artificial Intelligence (AI) In Medical Imaging Market, Segmentation by End User
The End User lens distinguishes deployment patterns across Hospitals and Imaging Centers, each with unique procurement, governance, and workflow needs. Large enterprises prioritize platform standardization, cybersecurity, and centralized model management, while independent centers emphasize cost-effective tools that boost throughput and referral satisfaction. Success depends on clinical engagement, training, and measurable outcomes tied to turnaround time and report quality.
Hospitals
Hospitals adopt AI to address staffing pressures, case complexity, and 24/7 service demands. Integrated solutions that support triage, automated measurements, and structured reporting create system-level efficiency. Governance committees, IT alignment, and phased rollouts reduce risk, while vendor partnerships enable continuous improvement and evidence generation to support enterprise value cases.
Imaging Centers
Imaging Centers seek rapid deployment, interoperability with heterogeneous equipment, and features that enhance patient throughput. Cloud-enabled offerings and usage-based models lower barriers to entry, with emphasis on intuitive UX and minimal workflow disruption. Competitive differentiation often hinges on faster turnaround and referring physician satisfaction, making reliable integration and support critical.
Artificial Intelligence (AI) In Medical Imaging Market, Segmentation by Geography
In this report, the Artificial Intelligence (AI) In Medical Imaging Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America demonstrates early adoption supported by mature reimbursement pathways, robust regulatory frameworks, and dense vendor–provider partnerships. Health systems invest in platform consolidation, model monitoring, and cybersecurity, prioritizing enterprise scalability. Competitive intensity drives rapid innovation cycles, with emphasis on measurable outcomes such as turnaround time reductions and standardized reporting across multi-site networks.
Europe
Europe emphasizes data protection, clinical validation, and cross-border interoperability, shaping procurement and deployment models. Public–private collaborations and research consortia accelerate evidence generation while regional funding supports modernization. Providers value explainability and governance, with a focus on equitable access and AI ethics that influence vendor differentiation and sustained trust.
Asia Pacific
Asia Pacific exhibits diverse adoption dynamics, from advanced urban centers deploying cutting-edge platforms to emerging markets prioritizing cost-effective triage and cloud options. Expanding imaging infrastructure, government digital health initiatives, and rising chronic disease burden act as growth drivers. Localization, language support, and flexible commercial models are essential to address heterogeneous clinical and IT environments.
Middle East & Africa
Middle East & Africa is investing in flagship facilities and national health strategies that include AI-enabled imaging modernization. Adoption focuses on scalable cloud deployments, vendor training, and service contracts that mitigate skill gaps. Partnerships with academic centers and OEMs support capacity building, while priorities include interoperability, cybersecurity, and sustainable operations across mixed public–private systems.
Latin America
Latin America adoption is paced by budget constraints and infrastructure variability, making value-based offerings and managed services attractive. Opportunities center on triage for high-volume modalities and standardized reporting that elevates referral satisfaction. Collaboration with local distributors and alignment to national digital health programs help vendors expand reach and deliver resilient workflows in diverse care settings.
Artificial Intelligence (AI) In Medical Imaging Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of AI in Medical Imaging Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing demand for early disease detection
- Growing accuracy of AI diagnostic tools
- Shortage of skilled radiologists
-
Rising adoption of AI-powered imaging solutions - The growing use of AI-powered imaging solutions is accelerating the transformation of diagnostic healthcare. These technologies offer significant advantages in speed, accuracy, and scalability, enabling healthcare providers to analyze large volumes of medical images efficiently. AI-driven tools are being widely adopted for applications like tumor detection, organ segmentation, fracture analysis, and anomaly identification, streamlining clinical workflows and supporting faster diagnosis.
Hospitals and diagnostic centers are integrating AI with imaging modalities such as CT scans, MRIs, X-rays, and ultrasounds to improve diagnostic accuracy and reduce manual interpretation time. These solutions can automatically detect patterns that may not be easily visible to human radiologists, enhancing early disease detection and intervention outcomes. This makes AI a valuable ally in addressing the growing volume of imaging data in modern healthcare systems.
The adoption is also driven by increasing demand for cost-effective healthcare delivery and improved patient outcomes. By reducing reporting delays and increasing throughput, AI systems contribute to more efficient resource utilization. Furthermore, cloud-based platforms are making AI imaging solutions more accessible, allowing smaller hospitals and rural facilities to benefit from advanced diagnostic capabilities without heavy investment in local infrastructure.
Vendors offering FDA-approved, interoperable, and clinician-friendly AI solutions are gaining traction in both developed and emerging markets. As awareness grows around the benefits of AI-assisted diagnostics, healthcare institutions are expected to continue scaling up their investments in intelligent imaging platforms that augment radiologist productivity and enhance clinical precision.
Restraints:
- Data privacy and patient consent concerns
- High costs of AI system integration
- Lack of standardization across AI platforms
-
Limited trust in AI-driven interpretations - Despite the capabilities of AI in medical imaging, a key restraint hindering market growth is the limited trust among clinicians in AI-generated interpretations. Many healthcare professionals remain cautious about relying solely on algorithms for critical decisions, especially in cases involving rare or complex pathologies. The perceived lack of transparency in black-box AI models makes it challenging for radiologists to validate and fully trust the outcomes.
This trust deficit is rooted in concerns over accuracy, explainability, and accountability. If an AI tool misidentifies a lesion or fails to detect a critical anomaly, the consequences can be severe. Radiologists and healthcare administrators often prefer systems that allow for human oversight and decision support, rather than autonomous interpretations. The limited interpretability of many AI models leads to skepticism about their clinical reliability and generalizability.
The variability in performance across different patient populations, imaging equipment, and clinical settings raises concerns about bias and inconsistent results. Without standardized validation and peer-reviewed evidence, healthcare providers hesitate to adopt these tools on a large scale. In addition, legal and ethical liabilities related to AI misdiagnosis remain unclear, further complicating implementation efforts.
This restraint, developers must focus on building transparent, explainable AI systems that align with clinician workflows and offer confidence-building validation metrics. Collaborative initiatives between AI vendors, healthcare professionals, and regulatory bodies will play a vital role in establishing clinical trust, safety standards, and real-world evidence that support responsible adoption of AI in diagnostics.
Opportunities:
- Integration with PACS and hospital workflows
- Advancements in multimodal imaging analysis
- Expansion into emerging healthcare markets
-
AI applications in personalized treatment planning - The integration of AI in personalized treatment planning represents a major opportunity for the AI in medical imaging market. As medicine shifts from a one-size-fits-all approach to precision healthcare, AI offers powerful tools for analyzing patient-specific data to inform tailored diagnosis and treatment strategies. Medical imaging is a critical input in this process, and AI enhances its value by enabling granular pattern recognition and predictive modeling.
AI can help identify disease progression patterns, anatomical variations, and treatment responses specific to individual patients. By correlating imaging data with electronic health records, genomics, and clinical biomarkers, AI systems can suggest personalized treatment paths, surgical plans, and therapy regimens. This supports more informed decision-making and improves outcomes for conditions such as cancer, cardiovascular disease, and neurological disorders.
In radiation therapy, AI algorithms optimize dose planning by analyzing tumor size, location, and tissue sensitivity, leading to more effective and safer treatments. In surgical planning, AI-enhanced imaging allows for better risk assessment and minimally invasive intervention. Such applications reduce complications, speed up recovery, and contribute to value-based healthcare delivery.
As healthcare providers look to improve clinical efficacy and patient satisfaction, the integration of AI imaging in personalized care offers a transformative advantage. Companies that develop AI platforms capable of seamless data integration, real-time image processing, and outcome prediction will be at the forefront of innovation in precision medicine and long-term care optimization.
Artificial Intelligence (AI) In Medical Imaging Market Competitive Landscape Analysis
Artificial Intelligence (AI) In Medical Imaging Market is witnessing rapid competition as companies in the Artificial Intelligence (AI) In Medical Imaging Market adopt advanced strategies to expand their positions. Firms are driving growth through collaboration, partnerships, and mergers with healthcare providers and imaging system manufacturers. Rising demand for precision diagnostics fuels rivalry, with ongoing innovation reshaping imaging solutions.
Market Structure and Concentration
The Artificial Intelligence (AI) In Medical Imaging Market reflects a semi-consolidated structure, with around 60% of share dominated by leading technology and healthcare firms. Strategic merger activity, solution expansion, and digital strategies sustain leadership. Market concentration is reinforced through collaboration with hospitals, research institutes, and technology developers, ensuring long-term growth and competitiveness.
Brand and Channel Strategies
In the Artificial Intelligence (AI) In Medical Imaging Market, firms employ brand-focused strategies to enhance visibility and adoption. Partnerships with imaging centers, diagnostic companies, and healthcare providers strengthen distribution channels. With nearly 55% of adoption linked to trust in accuracy, collaboration ensures consistent growth and builds brand reputation across healthcare ecosystems.
Innovation Drivers and Technological Advancements
The Artificial Intelligence (AI) In Medical Imaging Market is propelled by rapid technological advancements, with nearly 50% of developments tied to innovation in deep learning, image recognition, and predictive analytics. Continuous R&D collaboration drives new solutions, while adaptive strategies align with precision medicine. Ongoing expansion strengthens competitiveness across diagnostic applications.
Regional Momentum and Expansion
The Artificial Intelligence (AI) In Medical Imaging Market highlights strong regional expansion, with North America and Europe contributing nearly 65% of growth. Regional strategies include healthcare partnerships and government-backed projects, while collaboration with technology firms supports implementation. Adoption of technological advancements enhances competitiveness across developed and emerging markets.
Future Outlook
The Artificial Intelligence (AI) In Medical Imaging Market is expected to progress with strategies focused on sustainable growth, integration of AI tools, and improved clinical outcomes. Continued innovation in automated diagnostics, combined with stronger collaboration among healthcare providers and technology companies, will reinforce competitiveness. With steady expansion, the market’s future outlook highlights transformative potential in medical imaging.
Key players in Artificial Intelligence (AI) In Medical Imaging Market include:
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- NVIDIA Corporation
- IBM Watson Health
- Canon Medical Systems
- Fujifilm Holdings
- Agfa-Gevaert Group
- Zebra Medical Vision
- Lunit Inc.
- Aidoc Medical
- Arterys Inc.
- Enlitic Inc.
- Qure.ai Technologies
- iCAD Inc.
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By Modality
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Artificial Intelligence (AI) In Medical Imaging Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing demand for early disease detection
-
Growing accuracy of AI diagnostic tools
-
Shortage of skilled radiologists globally
-
Rising adoption of AI-powered imaging solutions
-
- Restraints
-
Data privacy and patient consent concerns
-
High costs of AI system integration
-
Lack of standardization across AI platforms
-
Limited trust in AI-driven interpretations
-
- Opportunities
-
Integration with PACS and hospital workflows
-
Advancements in multimodal imaging analysis
-
Expansion into emerging healthcare markets
-
AI applications in personalized treatment planning
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Artificial Intelligence (AI) In Medical Imaging Market, By Component, 2021 - 2031 (USD Million)
- Hardware
- Software
- Service
- Artificial Intelligence (AI) In Medical Imaging Market, By Modality, 2021 - 2031 (USD Million)
- MRI
- CT
- X-Ray
- Artificial Intelligence (AI) In Medical Imaging Market, By Application, 2021 - 2031 (USD Million)
- Radiology
- Cardio
- Cancer
- Lung
- Breast
- Prostate
- Artificial Intelligence (AI) In Medical Imaging Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Imaging Centers
- Artificial Intelligence (AI) In Medical Imaging Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Artificial Intelligence (AI) In Medical Imaging Market, By Component, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- NVIDIA Corporation
- IBM Watson Health
- Canon Medical Systems
- Fujifilm Holdings
- Agfa-Gevaert Group
- Zebra Medical Vision
- Lunit Inc.
- Aidoc Medical
- Arterys Inc.
- Enlitic Inc.
- Qure.ai Technologies
- iCAD Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market